Cleveland OH 结直肠癌临床试验
24项针对 结直肠癌的研究正在 Cleveland及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中欢迎健康志愿者
- Louis Stokes Cleveland VA Medical Center, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- The Cleveland Clinic Taussig Cancer Center, Cleveland
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
招募中2 期
- Cleveland Clinic - Oncology Department, Cleveland
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
招募中1 期
- Exelixis Clinical Site #10, Cleveland
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- University Hospitals Cleveland Medical Center, Cleveland
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
招募中3 期
- University Hospital of Cleveland, Cleveland
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
招募中3 期
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Cancer Center Fairview Hospital Moll Pavilion, Cleveland
- Taussig Cancer Insititute Cleveland Clinic, Cleveland
- 以及另外 2 项
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
招募中1/2 期
- Cleveland Clinic, Cleveland
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
招募中3 期
- Case Comprehensive Cancer Center, Cleveland
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
招募中
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
招募中1 期
- Cleveland Clinic Foundation, Cleveland
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
招募中3 期
- Clinical Study Site, Cleveland
- Clinical Study Site, Cleveland
- Clinical Study Site, Mayfield Heights · 距离 12 英里
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- Cleveland Clinic, Cleveland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
招募中1/2 期
- Cleveland Clinic, Cleveland
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
招募中1/2 期
- Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
招募中1 期
- University Hospitals - UH Cleveland Medical Center, Cleveland
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
招募中1 期
- Cleveland Clinic, Taussig Cancer Institute, Cleveland
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
招募中观察性研究
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
招募中观察性研究欢迎健康志愿者
- Cleveland Clinic, Cleveland
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
招募中1/2 期
- Cleveland Clinic Foundation, Cleveland
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
招募中1 期
- Cleveland Clinic, Cleveland
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
招募中1/2 期
- Cleveland Clinic, Cleveland
其他城市的 结直肠癌试验
- Houston, TX102 项研究
- New York City, NY78 项研究
- Nashville, TN69 项研究
- Boston, MA63 项研究
- Los Angeles, CA59 项研究
- Arlington, VA52 项研究
- St. Louis, MO50 项研究
- San Antonio, TX46 项研究
- Philadelphia, PA44 项研究
- Grand Rapids, MI40 项研究
- Baldwin Park, CA37 项研究
- Chicago, IL34 项研究
Cleveland的其他研究
- 非小细胞肺癌43 项研究
- 癌症（所有类型）36 项研究
- 乳腺癌35 项研究
- 前列腺癌34 项研究
- 心力衰竭33 项研究
- 卵巢癌30 项研究
- 转移性癌症30 项研究
- 肺癌26 项研究
- 心血管疾病22 项研究
- 子宫内膜癌20 项研究
- 急性髓系白血病20 项研究
- 克罗恩病19 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。